Standout Papers

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-... 2014 2026 2018 2022 345
  1. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study (2014)
    Rayid Abdulqawi, Rachel Dockry et al. The Lancet

Immediate Impact

2 from Science/Nature 59 standout
Sub-graph 1 of 18

Citing Papers

A new era of cancer phototherapy: mechanisms and applications
2024 Standout
A body–brain circuit that regulates body inflammatory responses
2024 StandoutNature
3 intermediate papers

Works of Kimberley Holt being referenced

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
2014 Standout

Author Peers

Author Last Decade Papers Cites
Kimberley Holt 1018 882 197 323 33 1.4k
Rachel Dockry 864 680 156 244 30 1.1k
Kevin Kwong 597 560 33 654 26 1.2k
David Walk 131 459 10 69 46 1.5k
Nicola C. Day 864 767 50 47 25 1.7k
John F. Tucker 60 462 42 97 33 1.2k
David Farmer 188 346 9 111 22 1.1k
Chikako Ikeda 83 168 18 32 49 1.0k
George Gallos 181 244 9 111 46 1.2k
Margaret Minkwitz 406 574 33 29 23 1.6k
J. G. Murray 137 280 4 45 23 1.5k

All Works

Loading papers...

Rankless by CCL
2026